Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Borges de Souza

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Endocrinology|August 25, 2018
Is receptor profiling useful for predicting pituitary therapy?Monica Marazuela, Ana M Ramos-Leví, Patricia Borges de Souza, et al.
Frontiers in Endocrinology|April 2, 2020
Update on Fundamental Mechanisms of Thyroid CancerAlessandro Prete, Patricia Borges de Souza, Simona Censi, et al.
Frontiers in Endocrinology|February 25, 2021
NEP-Score Thresholds Predict Survival of Patients With Bronchial CarcinoidsIrene Gagliardi, Mario Tarquini, Maria Rosaria Ambrosio, et al.
Neuroendocrinology|October 24, 2024
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot StudyIrene Gagliardi, Federica Campolo, Patricia Borges de Souza, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 25, 2019
Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell typesMercedes Del Rio-Moreno, Emilia Alors-Perez, Patricia Borges de Souza, et al.
HLA|January 14, 2025
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 SeverityLucia Mazzotti, Patricia Borges de Souza, Irene Azzali, et al.
Frontiers in Immunology|February 25, 2025
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapyAnna De Lucia, Lucia Mazzotti, Anna Gaimari, et al.
Cell Chemical Biology|September 14, 2021
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporterMartin L Read, Katie Brookes, Caitlin E M Thornton, et al.
International Journal of Molecular Sciences|November 27, 2024
Significant Advancements and Evolutions in Chimeric Antigen Receptor DesignAnna Gaimari, Anna De Lucia, Fabio Nicolini, et al.
Scientific Reports|November 5, 2025
First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19Sara Bravaccini, Fabio Nicolini, William Balzi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Endocrinology|August 25, 2018
Is receptor profiling useful for predicting pituitary therapy?Monica Marazuela, Ana M Ramos-Leví, Patricia Borges de Souza, et al.
Frontiers in Endocrinology|April 2, 2020
Update on Fundamental Mechanisms of Thyroid CancerAlessandro Prete, Patricia Borges de Souza, Simona Censi, et al.
Frontiers in Endocrinology|February 25, 2021
NEP-Score Thresholds Predict Survival of Patients With Bronchial CarcinoidsIrene Gagliardi, Mario Tarquini, Maria Rosaria Ambrosio, et al.
Neuroendocrinology|October 24, 2024
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot StudyIrene Gagliardi, Federica Campolo, Patricia Borges de Souza, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 25, 2019
Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell typesMercedes Del Rio-Moreno, Emilia Alors-Perez, Patricia Borges de Souza, et al.
HLA|January 14, 2025
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 SeverityLucia Mazzotti, Patricia Borges de Souza, Irene Azzali, et al.
Frontiers in Immunology|February 25, 2025
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapyAnna De Lucia, Lucia Mazzotti, Anna Gaimari, et al.
Cell Chemical Biology|September 14, 2021
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporterMartin L Read, Katie Brookes, Caitlin E M Thornton, et al.
International Journal of Molecular Sciences|November 27, 2024
Significant Advancements and Evolutions in Chimeric Antigen Receptor DesignAnna Gaimari, Anna De Lucia, Fabio Nicolini, et al.
Scientific Reports|November 5, 2025
First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19Sara Bravaccini, Fabio Nicolini, William Balzi, et al.
Pageof 2